India's fight against viral hepatitis has entered its ninth year as the National Viral Hepatitis Control Programme (NVHCP) commemorates eight years since its nationwide rollout. Launched to address a significant public health challenge, the programme has worked systematically to reduce the burden of hepatitis B and C infections across the country.
Understanding Viral Hepatitis
Viral hepatitis refers to inflammation of the liver caused by viral infections, primarily hepatitis A, B, C, D, and E. Among these, hepatitis B and C are particularly concerning as they can lead to chronic liver disease, cirrhosis, and liver cancer if left untreated. India has historically carried a substantial burden of hepatitis cases, with millions affected by chronic hepatitis B and C infections.
The hepatitis B virus spreads through contact with infected blood or bodily fluids, while hepatitis C primarily transmits through blood-to-blood contact. Both conditions often remain asymptomatic for years, making screening and early detection crucial for preventing long-term complications.
Programme Structure and Goals
The NVHCP was designed as a comprehensive initiative addressing multiple aspects of hepatitis control. The programme focuses on three primary pillars: prevention through vaccination, early detection through screening, and providing access to treatment for those diagnosed with chronic infections.
Prevention efforts centre on hepatitis B vaccination, particularly targeting newborns and high-risk groups. India has integrated hepatitis B vaccine into its universal immunisation programme, ensuring infants receive protection from birth. Healthcare workers, family members of infected individuals, and other vulnerable populations also receive priority vaccination.
Screening and Diagnostic Services
One of the programme's significant achievements has been expanding screening facilities across the country. The initiative has established screening centres at various healthcare levels, from primary health centres to tertiary care hospitals. These facilities offer free or subsidised testing for hepatitis B and C, enabling wider population access to diagnostic services.
Early detection allows for timely intervention, preventing disease progression and reducing transmission risks. The programme emphasises screening pregnant women, blood donors, and individuals with risk factors such as injectable drug use or previous blood transfusions.
Treatment Access and Affordability
Access to antiviral treatment represents a cornerstone of the programme's success. Hepatitis C treatment has undergone revolutionary changes in recent years with the development of direct-acting antiviral drugs that can cure the infection in 8-12 weeks with minimal side effects. The programme has worked to make these medications affordable and accessible through government health facilities.
For hepatitis B, which requires long-term management rather than cure, the programme provides access to antiviral medications that suppress viral replication and prevent liver damage progression. Regular monitoring and follow-up care form integral components of chronic hepatitis B management.
Public Awareness and Education
The NVHCP recognises that combating viral hepatitis requires public awareness alongside medical interventions. Educational campaigns aim to reduce stigma associated with hepatitis infections, encourage testing among at-risk populations, and promote preventive behaviours.
Healthcare worker training represents another crucial element, ensuring medical professionals across India's vast healthcare system can identify, diagnose, and manage hepatitis cases effectively. This capacity building extends from metropolitan hospitals to rural health centres.
Challenges and Future Directions
Despite progress, challenges remain in achieving the World Health Organisation's goal of eliminating viral hepatitis as a public health threat by 2030. These include reaching remote populations, maintaining uninterrupted supply chains for diagnostics and medications, and ensuring sustained political and financial commitment.
The programme continues evolving to address gaps in service delivery, improve data collection for better programme monitoring, and integrate hepatitis services with other health initiatives for greater efficiency. Expanding screening coverage and ensuring treatment completion for all diagnosed patients remain priorities.
Impact on Public Health
The eight-year journey of the NVHCP represents India's commitment to addressing preventable diseases that disproportionately affect vulnerable populations. By combining prevention, early detection, and treatment, the programme offers a comprehensive approach to reducing hepatitis-related morbidity and mortality.
As the programme moves forward, continued investment, innovation in service delivery, and community engagement will prove essential for achieving the ambitious goal of a hepatitis-free India.
This article is for general informational purposes only. If you have concerns about hepatitis or liver health, please consult qualified healthcare professionals for proper diagnosis and treatment recommendations tailored to your specific situation.
